Dicerna Pharmaceuticals

Home » Dicerna Pharmaceuticals

Secondary

Dicerna Pharmaceuticals

Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of innovative, subcutaneously delivered RNAi-based therapeutics for diseases involving the liver, including rare diseases, chronic liver diseases, cardiovascular diseases, and viral infectious diseases.

Symbol

DRNA

Last Closing Price
$7.84

Shares
5,700,000

Effective Date
December 14, 2017

Underwriters
Stifel, Evercore ISI

To view the prospectus for Dicerna Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253